India Plans Tighter Enforcement At State Level To Counter Spread Of Spurious Drugs
This article was originally published in PharmAsia News
Executive Summary
India plans to step-up enforcement as some generic drug manufacturers continue to take shortcuts, ignoring the prospect of harsh penalties under a law passed two years ago.